Mahoney Stephen F. 4
4 · Viridian Therapeutics, Inc.\DE · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Mahoney Stephen F.
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+440,565→ 440,565 totalExercise: $14.41Exp: 2035-03-03→ Common Stock (440,565 underlying) - Award
Restricted Stock Units
2025-03-03+73,428→ 73,428 total→ Common Stock (73,428 underlying)
Footnotes (3)
- [F1]The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. The date of the grant is March 3, 2025.
- [F2]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.
- [F3]The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date.